Jack Jallo

Dr. Jack Jallo

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in The Lancet
Verified
Journal Article
Closed access
DHDaniel F Hanley
Daniel F Hanley
RTRichard E Thompson
Richard E Thompson
MRMichael Rosenblum
Michael Rosenblum
GYGayane Yenokyan
Gayane Yenokyan
KLKaren Lane
Karen Lane
AZAli Zomorodi
Ali Zomorodi

1 May 2002 in Journal of Neurotrauma
Verified
Journal Article
Closed access
RNRaj K. Narayan
Raj K. Narayan
MMMary Ellen Michel
Mary Ellen Michel
BABeth Ansell
Beth Ansell
ABAlex Baethmann
Alex Baethmann
ABAnat Biegon
Anat Biegon
LYLorraine Yurkewicz
Lorraine Yurkewicz
Traumatic brain injury (TBI) remains a major public health problem globally. In the United States the incidence of closed head injuries admitted to hospitals is conservatively estimated to be 200 per 100,000 population, and the incidence of penetrating head injury is estimated to be 12 per 100,000, the highest of any developed country in the world. This yields an approximate number of 500,000 new cases each year, a sizeable proportion of which demonstrate signficant long-term disabilities. Unfortunately, there is a paucity of proven therapies for this disease. For a variety of reasons, clinical trials for this condition have been difficult to design and perform. Despite promising pre-clinical data, most of the trials that have been performed in recent years have failed to demonstrate any significant improvement in outcomes. The reasons for these failures have not always been apparent and any insights gained were not always shared. It was therefore feared that we were running the risk of repeating our mistakes. Recognizing the importance of TBI, the National Institute of Neurological Disorders and Stroke (NINDS) sponsored a workshop that brought together experts from clinical, research, and pharmaceutical backgrounds. This workshop proved to be very informative and yielded many insights into previous and future TBI trials. This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research.

1 February 2017 in The Lancet
Verified
Journal Article
Closed access
DHDaniel F Hanley
Daniel F Hanley
KLKaren Lane
Karen Lane
NMNichol McBee
Nichol McBee
WZWendy Ziai
Wendy Ziai
STStanley Tuhrim
Stanley Tuhrim
IAIssam A Awad
Issam A Awad

1 November 2017 in Critical Care Medicine
Verified
Journal Article
Closed access
DODavid O. Okonkwo
David O. Okonkwo
LSLori Shutter
Lori Shutter
CMCarol Ma Moore
Carol Ma Moore
NTNancy R. Temkin
Nancy R. Temkin
APAva M. Rn Puccio
Ava M. Rn Puccio
RDRamon R. Diaz-Arrastia
Ramon R. Diaz-Arrastia
Objectives: A relationship between reduced brain tissue oxygenation and poor outcome following severe traumatic brain injury has been reported in observational studies. We designed a Phase II trial to assess whether a neurocritical care management protocol could improve brain tissue oxygenation levels in patients with severe traumatic brain injury and the feasibility of a Phase III efficacy study. Design: Randomized prospective clinical trial. Setting: Ten ICUs in the United States. Patients: One hundred nineteen severe traumatic brain injury patients. Interventions: Patients were randomized to treatment protocol based on intracranial pressure plus brain tissue oxygenation monitoring versus intracranial pressure monitoring alone. Brain tissue oxygenation data were recorded in the intracranial pressure –only group in blinded fashion. Tiered interventions in each arm were specified and impact on intracranial pressure and brain tissue oxygenation measured. Monitors were removed if values were normal for 48 hours consecutively, or after 5 days. Outcome was measured at 6 months using the Glasgow Outcome Scale–Extended. Measurements and Main Results: A management protocol based on brain tissue oxygenation and intracranial pressure monitoring reduced the proportion of time with brain tissue hypoxia after severe traumatic brain injury (0.45 in intracranial pressure–only group and 0.16 in intracranial pressure plus brain tissue oxygenation group; p < 0.0001). Intracranial pressure control was similar in both groups. Safety and feasibility of the tiered treatment protocol were confirmed. There were no procedure-related complications. Treatment of secondary injury after severe traumatic brain injury based on brain tissue oxygenation and intracranial pressure values was consistent with reduced mortality and increased proportions of patients with good recovery compared with intracranial pressure–only management; however, the study was not powered for clinical efficacy. Conclusions: Management of severe traumatic brain injury informed by multimodal intracranial pressure and brain tissue oxygenation monitoring reduced brain tissue hypoxia with a trend toward lower mortality and more favorable outcomes than intracranial pressure–only treatment. A Phase III randomized trial to assess impact on neurologic outcome of intracranial pressure plus brain tissue oxygenation–directed treatment of severe traumatic brain injury is warranted.

1 March 2016 in The Spine Journal
Verified
Journal Article
Closed access
PMPaul G. Matz
Paul G. Matz
RMR.J. Meagher
R.J. Meagher
TLTim Lamer
Tim Lamer
WTWilliam L. Tontz
William L. Tontz
TAThiru M. Annaswamy
Thiru M. Annaswamy
JWJens-Peter Witt
Jens-Peter Witt

1 February 2014 in Critical Care Medicine
Verified
Journal Article
Closed access
FRFred Rincon
Fred Rincon
JKJoon Kang
Joon Kang
MMMitchell Maltenfort
Mitchell Maltenfort
MVMatthew Vibbert
Matthew Vibbert
JUJacqueline Urtecho
Jacqueline Urtecho
RBRodney Bell
Rodney Bell
To test the hypothesis that hyperoxia was associated with higher in-hospital mortality in ventilated stroke patients admitted to the ICU. Retrospective multicenter cohort study. Primary admissions of ventilated stroke patients with acute ischemic stroke, subarachnoid hemorrhage, and intracerebral hemorrhage who had arterial blood gases within 24 hours of admission to the ICU at 84 U.S. ICUs between 2003 and 2008. Patients were divided into three exposure groups: hyperoxia was defined as PaO2 ≥ 300 mm Hg (39.99 kPa), hypoxia as any PaO2<60 mm Hg (7.99 kPa) or PaO2/FiO2 ratio ≤ 300, and normoxia, not defined as hyperoxia or hypoxia. The primary outcome was in-hospital mortality. Two thousand eight hundred ninety-four patients. Patients were divided into three exposure groups: hyperoxia was defined as PaO2 more than or equal to 300 mm Hg (39.99 kPa), hypoxia as any PaO2 less than 60 mm Hg (7.99 kPa) or PaO2/FIO2 ratio less than or equal to 300, and normoxia, not defined as hyperoxia or hypoxia. The primary outcome was in-hospital mortality. Exposure to hyperoxia. Over the 5-year period, we identified 554 ventilated patients with acute ischemic stroke (19%), 936 ventilated patients with subarachnoid hemorrhage (32%), and 1,404 ventilated patients with intracerebral hemorrhage (49%) of whom 1,084 (38%) were normoxic, 1,316 (46%) were hypoxic, and 450 (16%) were hyperoxic. Mortality was higher in the hyperoxia group as compared with normoxia (crude odds ratio 1.7 [95% CI 1.3-2.1]; p < 0.0001) and hypoxia groups (crude odds ratio, 1.3 [95% CI, 1.1-1.7]; p < 0.01). In a multivariable analysis adjusted for admission diagnosis, other potential confounders, the probability of being exposed to hyperoxia, and hospital-specific effects, exposure to hyperoxia was independently associated with in-hospital mortality (adjusted odds ratio, 1.2 [95% CI, 1.04-1.5]). In ventilated stroke patients admitted to the ICU, arterial hyperoxia was independently associated with in-hospital death as compared with either normoxia or hypoxia. These data underscore the need for studies of controlled reoxygenation in ventilated critically ill stroke populations. In the absence of results from clinical trials, unnecessary oxygen delivery should be avoided in ventilated stroke patients.